14th Medical Education Workshop on Molecular Targeted Therapy of Cancer, Sorrento, Italy, May 10-11,2013
The Medical Education Initiative on Molecular Targeted Therapy of Cancer (MTTC), has been developed to provide high quality education programmes for medical oncologists, in response to the expanding knowledge of molecular biology and new targets for cancer therapy. ecancer members are elligible for a €50 discount on the registration fee.
During this 14th live educational workshop will be held in Sorrento, Italy on May 10-11,2013, internationally recognized oncology experts will present the latest developments in molecular biology, targets for cancer therapeutics and impact of new drugs in the clinic.
Aim of the workshop
The Medical Education Initiative on Molecular Targeted Therapy of Cancer (MTTC), established in 2001 and directed by the International Education Council (IEC), was developed to provide high quality medical education programs for medical oncologists, in response to the expanding knowledge of molecular biology and new targets for cancer therapy.
The Core Educational Curriculum comprises:
After attending this live educational workshop, learners will be able to:
Medical oncologists with an interest in the molecular basis of cancer, molecular targeted therapy and clinical application of the new drugs.
The “14th International Medical Education Workshop on Molecular Targeted Therapy of Cancer - Sorrento, Italy - 10-11 May 2013” has been accredited with 10 (ten) ESMO-MORA points Category 1.
€50 discount to the first 50 ecancer members to register to this conference!
When registering select option 2 on the registration form and then write 'ecancer' next to it. Be sure to use the same name and email as your ecancer registration.
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.